FDMT vs KR · rev $37.0K vs P/E 19, rev $147.12B
4D Molecular Therapeutics Inc (FDMT) versus Kroger Company (KR) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Kroger Company (KR) is a grocery stores company listed on US.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
Latest reported KR revenue for 2025-02-01 was $147.12B. Net income was $2.67B. KR currently screens at market cap $46.17B and trailing P/E 19.0.
FDMT currently screens at market cap $518.1M. KR currently screens at market cap $46.17B and trailing P/E 19.0.
Not investment advice. Open the FDMT and KR stock pages for the full models.
Not investment advice.